Publications by authors named "Matteo Parma"

Claim this Profile
P
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT.
Ivan Moiseev, Mouad Abouqateb, Christophe Peczynski, Alessandro Busca, Nicolaus Kröger, Matteo Parma

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor selection in PTCy haploidentical transplant for acute lymphoblastic leukemia: a study from the ALWP of the EBMT.
Jaime Sanz, Allain-Thibeault Ferhat, Anna Maria Raiola, Didier Blaise, Mutlu Arat, Matteo Parma

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.
Nicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, Mattia Algeri, Alessandra Algarotti, Matteo Parma

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study in steroid-refractory acute graft versus host disease: Comparison of efficacy and tolerability of ruxolitinib alone or ruxolitinib in association with extracorporeal photopheresis or extracorporeal photopheresis monotherapy.
Marta Lisa Battista, Gabriele Facchin, Maria De Martino, Patrizia Chiusolo, Domenico Russo, Matteo Parma

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients With Acute Myeloid Leukemias or Myelodysplastic Syndromes After Relapsing From Allogeneic Stem Cell Transplantation: The GITMO AML/MDS-Relapse Registry Study.
Michele Malagola, Luca Castagna, Domenica Matranga, Vera Radici, Mirko Farina, Matteo Parma

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry-Based Study on Behalf of the "Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare" (GITMO).
Irene Defrancesco, Virginia Valeria Ferretti, Patrizia Chiusolo, Domenico Russo, Chiara Nozzoli, Matteo Parma

Am J Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party.
Nico Gagelmann, Moniek de Witte, Christophe Peczynski, William Boreland, Annoek E C Broers, Matteo Parma

Blood Cancer J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy.
Beatrice Manghisi, Giulia Cotilli, Marilena Fedele, Paola Perfetti, Elisabetta Terruzzi, Matteo Parma

Front Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation.
Chiara Nozzoli, Martina Pucillo, Luisa Giaccone, Alessandro Rambaldi, Maria Teresa Lupo Stanghellini, Matteo Parma

Transplant Cell Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making.
Ivan Civettini, Arianna Zappaterra, Bianca Maria Granelli, Giovanni Rindone, Andrea Aroldi, Matteo Parma

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis.
Alex Pezzotta, Ilaria Gentile, Donatella Genovese, Maria Grazia Totaro, Cristina Battaglia, Matteo Parma

Pharmacol Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01.
Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori, Fabio Giglio, Mario Arpinati, Matteo Parma

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation.
Elisa Diral, Matteo Parma, Rossella Renso, Sara Pezzatti, Elisabetta Terruzzi

Leuk Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab.
Andrea Bacigalupo, Emanuele Angelucci, Anna Maria Raiola, Riccardo Varaldo, Carmen Di Grazia, Matteo Parma

Bone Marrow Transplant· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of NIPBL leads to impaired RUNX1 expression and haematopoietic defects.
Mara Mazzola, Alex Pezzotta, Grazia Fazio, Alessandra Rigamonti, Erica Bresciani, Matteo Parma

J Cell Mol Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).
Anna Candoni, Alessandro Rambaldi, Renato Fanin, Andrea Velardi, William Arcese, Matteo Parma

Biol Blood Marrow Transplant· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
:
: a new player in myeloid cell differentiation.
Mara Mazzola, Gianluca Deflorian, Alex Pezzotta, Laura Ferrari, Grazia Fazio, Matteo Parma

Haematologica· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes.
Giulia Falconi, Emiliano Fabiani, Alfonso Piciocchi, Marianna Criscuolo, Luana Fianchi, Matteo Parma

Leukemia· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO).
Beatrice Bassetti, Corrado Carbucicchio, Valentina Catto, Elisa Gambini, Erica Rurali, Matteo Parma

Stem Cell Res Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.
Martino Introna, Federico Lussana, Alessandra Algarotti, Elisa Gotti, Rut Valgardsdottir, Matteo Parma

Biol Blood Marrow Transplant· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.
Erica Dander, Paola De Lorenzo, Barbara Bottazzi, Paola Quarello, Paola Vinci, Matteo Parma

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe, reversible nelarabine-induced neuropathy and myelopathy.
Paola Alberti, Matteo Parma, Pietro Pioltelli, Enrico Maria Pogliani, Elisabetta Terruzzi

J Peripher Nerv Syst· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy.
Daniela Belotti, Giuseppe Gaipa, Beatrice Bassetti, Benedetta Cabiati, Gabriella Spaltro, Matteo Parma

Biomed Res Int· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic Transplantation, after Obtaining a Good Molecular Remission.
Matteo Parma, Clara Viganò, Monica Fumagalli, Federica Colnaghi, Arianna Colombo

Mediterr J Hematol Infect Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications.
Angelo Belotti, Lorena Duca, Lorenza Borin, Silvia Realini, Rossella Renso, Matteo Parma

Leuk Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis